Back

I am very happy that we were able to recently secure #EU funding for some pragmatic #ClinicalTrials. However I found out that there is a hard time limit attached to it: 5 years.
I mean... we are struggling to make that (largely due to the regulatory burden ALSO originating in the #CTR and another #EU organ) in a study designed for * recurrent #GBM * patients.
Is it oversimplifying too much to say that no breast or prostate application to this call ever stood a chance in this grant call?